Sections View Full Chapter Figures Tables Videos Annotate Full Chapter Figures Tables Videos Supplementary Content ++ For further information, see CMDT Part 20-23: Levamisole-Associated Purpura +++ Key Features ++ Levamisole is a prevalent adulterant of illicit cocaine in North America Exposure can induce a distinctive clinical syndrome of retiform purpura and cutaneous necrosis affecting the Extremities Ears Skin overlying the zygomatic arch Long-term sequelae of levamisole exposure include Deforming cutaneous lesions Arthralgias Arthritis +++ Clinical Findings ++ The syndrome is associated with The lupus anticoagulant IgM antibodies to cardiolipin Very high titers of p-ANCAs (due to autoantibodies to elastase, lactoferrin, cathepsin-G, and other neutrophil components rather than to myeloperoxidase alone) Use of levamisole-adulterated cocaine also has been linked to Neutropenia Agranulocytosis Pauci-immune glomerulonephritis +++ Diagnosis ++ Biopsies reveal widespread thrombosis of small cutaneous vessels with varying degrees of vasculitis +++ Treatment ++ There is no consensus on treatment, but early lesions can resolve with abstinence Your Access profile is currently affiliated with [InstitutionA] and is in the process of switching affiliations to [InstitutionB]. Please select how you would like to proceed. Keep the current affiliation with [InstitutionA] and continue with the Access profile sign in process Switch affiliation to [InstitutionB] and continue with the Access profile sign in process Get Free Access Through Your Institution Learn how to see if your library subscribes to McGraw Hill Medical products. Subscribe: Institutional or Individual Sign In Error: Incorrect UserName or Password Username Error: Please enter User Name Password Error: Please enter Password Sign in Forgot Password? Forgot Username? Sign in via OpenAthens Sign in via Shibboleth You already have access! Please proceed to your institution's subscription. Create a free profile for additional features.